This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Msall, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Msall, M. E.
Related Collections
Right arrow Premature & Newborn

PEDIATRICS Vol. 106 No. 5 November 2000, pp. 998-1005

Severity of Neonatal Retinopathy of Prematurity Is Predictive of Neurodevelopmental Functional Outcome at Age 5.5 Years

Received Sept 21, 1999; accepted Mar 17, 2000.

Michael E. Msall*, Dale L. PhelpsDagger , Kathleen M. DiGaudio§, Velma Dobsonparallel , Betty Tung, Richard E. McClead#, Graham E. Quinn**, James D. ReynoldsDagger Dagger , Robert J. Hardy, Earl A. Palmer§§, and on Behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group

From the * Child Development Center, Hasbro Children's Hospital, Brown University School of Medicine, Providence, Rhode Island; Dagger  Children's Hospital at Strong, University of Rochester, Rochester, New York; § Robert Warner Rehabilitation Center, Children's Hospital of Buffalo, State University of New York at Buffalo, Buffalo, New York; parallel  University of Arizona, Tucson, Arizona;  University of Texas Health Science Center, Coordinating Center for Clinical Trials, Houston, Texas; # Children's Hospital, Ohio State University, Columbus, Ohio; ** The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania; Dagger Dagger  Children's Hospital of Buffalo, State University of New York at Buffalo, Buffalo, New York; and §§ Casey Eye Institute, Oregon Health Sciences University, Portland, Oregon.

Objective.  The purpose of this study was to assess the relation between neonatal retinopathy of prematurity (ROP) in very low birth weight infants and neurodevelopmental function at age 5.5 years.

Methods.  Longitudinal follow-up of children occurred in 2 cohorts of the Multicenter Cryotherapy for Retinopathy of Prematurity Study. The extended natural history cohort followed 1199 survivors of <1251 g birth weight from 5 centers. The threshold randomized cohort (ThRz) followed 255 infants <1251 g from 23 centers who developed threshold ROP and who consented to cryotherapy to not more than 1 eye. At 5.5 years both cohorts had ophthalmic and acuity testing and neurodevelopmental functional status determined with the Functional Independence Measure for Children (WeeFIM).

Results.  Evaluations were completed on 88.7% of the extended natural history cohort; 87% had globally normal functional skills (WeeFIM: >95). As ROP severity increased, rates of severe disability increased from 3.7% among those with no ROP, to 19.7% of those with threshold ROP. Multiple logistic regression analysis demonstrated that better functional status was associated with favorable visual acuity, favorable 2-year neurological score, absence of threshold ROP, having private health insurance, and black race. Evaluations were completed on 87.4% of the ThRz children. In each functional domain, the 134 children with favorable acuity in their better eye had fewer disabilities than did the 82 children with unfavorable acuity: self-care disability 25.4% versus 76.8%, continency disability 4.5% versus 50.0%, motor disability 5.2% versus 42.7%, and communicative-social cognitive disability 22.4% versus 65.9%, respectively.

Conclusion.  Severity of neonatal ROP seems to be a marker for functional disability at age 5.5 years among very low birth weight survivors. High rates of functional limitations in multiple domains occur in children who had threshold ROP, particularly if they have unfavorable visual acuity.  Key words:  retinopathy of prematurity, very low birth weight, developmental outcomes, longitudinal studies, prematurity, blindness, vision disorders, developmental disabilities, functional independence.




This article has been cited by other articles:


Home page
NEJMHome page
B. Schmidt, R. S. Roberts, P. Davis, L. W. Doyle, K. J. Barrington, A. Ohlsson, A. Solimano, W. Tin, and the Caffeine for Apnea of Prematurity Trial Group
Long-Term Effects of Caffeine Therapy for Apnea of Prematurity
N. Engl. J. Med., November 8, 2007; 357(19): 1893 - 1902.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. L. Gianni, O. Picciolini, C. Vegni, L. Gardon, M. Fumagalli, and F. Mosca
Twelve-Month Neurofunctional Assessment and Cognitive Performance at 36 Months of Age in Extremely Low Birth Weight Infants
Pediatrics, November 1, 2007; 120(5): 1012 - 1019.
[Abstract] [Full Text] [PDF]


Home page
Neurorehabil Neural RepairHome page
S. S. N. Wong and V. C. N. Wong
Functional Independence Measure for Children: A Comparison of Chinese and Japanese Children
Neurorehabil Neural Repair, January 1, 2007; 21(1): 91 - 96.
[Abstract] [PDF]


Home page
PediatricsHome page
V. Tommiska, K. Heinonen, L. Lehtonen, M. Renlund, T. Saarela, O. Tammela, M. Virtanen, and V. Fellman
No Improvement in Outcome of Nationwide Extremely Low Birth Weight Infant Populations Between 1996-1997 and 1999-2000
Pediatrics, January 1, 2007; 119(1): 29 - 36.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. E. Msall
The Limits of Viability and the Uncertainty of Neuroprotection: Challenges in Optimizing Outcomes in Extreme Prematurity
Pediatrics, January 1, 2007; 119(1): 158 - 160.
[Full Text] [PDF]


Home page
NeoReviewsHome page
L. Romantseva and M. E Msall
Advances in Understanding Cerebral Palsy Syndromes After Prematurity
NeoReviews, November 1, 2006; 7(11): e575 - e585.
[Full Text] [PDF]


Home page
PediatricsHome page
C. Lofqvist, E. Engstrom, J. Sigurdsson, A.-L. Hard, A. Niklasson, U. Ewald, G. Holmstrom, L. E. H. Smith, and A. Hellstrom
Postnatal head growth deficit among premature infants parallels retinopathy of prematurity and insulin-like growth factor-1 deficit.
Pediatrics, June 1, 2006; 117(6): 1930 - 1938.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. E. Msall
The retina as a window to the brain in vulnerable neonates.
Pediatrics, June 1, 2006; 117(6): 2287 - 2289.
[Full Text] [PDF]


Home page
PediatricsHome page
S. R. Hintz, D. E. Kendrick, B. R. Vohr, W. K. Poole, R. D. Higgins, and for the National Institute of Child Health and Hum
Changes in Neurodevelopmental Outcomes at 18 to 22 Months' Corrected Age Among Infants of Less Than 25 Weeks' Gestational Age Born in 1993-1999
Pediatrics, June 1, 2005; 115(6): 1645 - 1651.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. E. Msall
Developmental Vulnerability and Resilience in Extremely Preterm Infants
JAMA, November 17, 2004; 292(19): 2399 - 2401.
[Full Text] [PDF]


Home page
Arch OphthalmolHome page
CRYO-ROP Cooperative Group
Health-Related Quality of Life at Age 10 Years in Very Low-Birth-Weight Children With and Without Threshold Retinopathy of Prematurity
Arch Ophthalmol, November 1, 2004; 122(11): 1659 - 1666.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
Follow-up Care of High-Risk Infants
Pediatrics, November 1, 2004; 114(5/S1): 1377 - 1397.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. E. Msall, D. L. Phelps, R. J. Hardy, V. Dobson, G. E. Quinn, C. G. Summers, M. R. Tremont, and for the Cryotherapy for Retinopathy of Prematurity
Educational and Social Competencies at 8 Years in Children With Threshold Retinopathy of Prematurity in the CRYO-ROP Multicenter Study
Pediatrics, April 1, 2004; 113(4): 790 - 799.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
Early Treatment for Retinopathy of Prematurity Coo
Revised Indications for the Treatment of Retinopathy of Prematurity: Results of the Early Treatment for Retinopathy of Prematurity Randomized Trial
Arch Ophthalmol, December 1, 2003; 121(12): 1684 - 1694.
[Abstract] [Full Text] [PDF]


Home page
NeoReviewsHome page
W. Tin and E. Hey
The Medical Use of Oxygen: A Century of Research in Animals and Humans
NeoReviews, December 1, 2003; 4(12): e349 - 355.
[Full Text] [PDF]


Home page
JAMAHome page
B. Schmidt, E. V. Asztalos, R. S. Roberts, C. M. T. Robertson, R. S. Sauve, M. F. Whitfield, and for the Trial of Indomethacin Prophylaxis in Prete
Impact of Bronchopulmonary Dysplasia, Brain Injury, and Severe Retinopathy on the Outcome of Extremely Low-Birth-Weight Infants at 18 Months: Results From the Trial of Indomethacin Prophylaxis in Preterms
JAMA, March 5, 2003; 289(9): 1124 - 1129.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
Cryotherapy for Retinopathy of Prematurity Coopera
Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: Ophthalmological Outcomes at 10 Years
Arch Ophthalmol, August 1, 2001; 119(8): 1110 - 1118.
[Abstract] [Full Text] [PDF]


Home page
NeoReviewsHome page
D. L. Phelps
Retinopathy of Prematurity: Clinical Trials
NeoReviews, July 1, 2001; 2(7): e167 - 173.
[Full Text] [PDF]